Chemotherapy Before Surgery

Neoadjuvant chemotherapy means receiving cancer medicines before an operation. The medicines travel through the bloodstream, so they can treat cancer cells beyond the main tumour while the surgical team prepares for the next stage. The schedule and drug combination depend on the cancer type, stage, tumour biology, and your health.

This treatment is planned with your cancer team after reviewing your diagnosis and health.

Treatment may shrink a tumour, make surgery more manageable, or show how the cancer responds to the chosen medicines. This approach is used in selected Breast Cancer, Inflammatory Breast Cancer, and Rectal Cancer plans.

A medical oncologist checks your health, blood counts, kidney and liver function, medicines, and treatment goals. Chemotherapy is given in cycles through a vein or another planned route. Each visit includes checks for side effects; rest between treatments lets the body recover. Surgery is scheduled after the planned course when the team considers it appropriate.

Common effects can include tiredness, nausea, appetite changes, mouth soreness, altered taste, hair loss, and changes in blood counts. Some medicines can affect nerves, fertility, the heart, kidneys, or bladder. Your team can prescribe anti-sickness treatment and offer advice about food, activity, mouth care, and infection prevention.

Report fever or chills, difficulty breathing, chest pain, uncontrolled vomiting, severe diarrhoea, confusion, unusual bleeding, or inability to drink urgently. A low white-cell count can make infection serious even when symptoms seem mild.

The response to chemotherapy can be assessed before surgery, and the findings at surgery and pathology add information about the next treatment decision. Some tumours shrink or show little remaining disease; others respond less. Outcomes depend on cancer biology, stage, response, surgery, and later treatment, so an individual result cannot be promised.

Chemotherapy before surgery is planned as part of a sequence, not as an isolated visit. Blood tests and symptom checks help the team decide whether a cycle should proceed, change, or pause. Keep a written list of medicines and symptoms for each appointment.

It may be recommended when chemotherapy is expected to help control cancer before local treatment, when reducing tumour size could support surgery, or when early response information will guide the wider plan. The team considers the tumour’s biology, spread, symptoms, other illnesses, and personal priorities.

You check in, have observations and often a blood test, meet the treatment team, receive premedication if needed, and then receive the chemotherapy through the planned route. Staff observe you during and after administration. You leave with instructions on medicines, warning symptoms, and the date of the next review.

Side effects may begin during treatment or after you return home, depending on the medicine. Energy and appetite can fluctuate between cycles. Rest when needed, take prescribed medicines as directed, drink according to your team’s advice, and keep appointments for blood tests. Hair, taste, blood counts, and nerve symptoms may take time to settle after treatment ends.

Risks include infection from low blood counts, dehydration, allergic reactions, blood clots, organ effects, and effects on fertility. The exact risks depend on the medicines and your medical history. Tell the team about fever, new pain, bleeding, or symptoms that worsen rather than waiting for the next appointment.

Depending on the cancer, alternatives may include surgery first, Radiotherapy, hormone or targeted medicines, immunotherapy, or a combined plan. For some people, the sequence changes after scans, examination, side effects, or a change in treatment goals.

Choose a cancer service with medical oncology, surgery, imaging, pathology, nursing, and symptom-support expertise. Ask which medicines are planned, how infection concerns are handled after hours, how response will be checked, and how chemotherapy affects the timing of surgery.